Menopausal hormone therapy reduced the risk for psychosis relapse by 16% in women with schizophrenia or schizoaffective disorder, results of a real-world study show. Medscape Medical News
Menopausal hormone therapy reduced the risk for psychosis relapse by 16% in women with schizophrenia or schizoaffective disorder, results of a real-world study show. Medscape Medical News